Tech Company Financing Transactions
Aelius Biotech Funding Round
North East Venture Fund and Mercia Ventures participated in a $1.6 million venture round for Aelius Biotech. This venture round was announced on 11/23/2023.
Transaction Overview
Company Name
Announced On
11/23/2023
Transaction Type
Venture Equity
Amount
$1,580,000
Round
Undisclosed
Investors
North East Venture Fund (Lead Investor)
Proceeds Purpose
The company intends to use the funds to meet demand by relocating from the university into laboratories in Newcastle, and expand its five-strong team with the creation of ten new jobs in the next two years.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
The Biosphere, Draymans Way, Newcastle Helix
Newcastle Upon Tyne, NE4 5BX
UK
Newcastle Upon Tyne, NE4 5BX
UK
Phone
Website
Email Address
Overview
Aelius biotech specialise in the development of models of the mucosal surfaces of the human body. We currently have the capability to model the gastrointestinal tract and the airways, and are in the process of developing model systems to simulate the mucosal surfaces of the eye and cervico-vaginal tract.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Chater
Founder
Jeff Pearson
Founder
Matt Wilcox
Browse more venture capital transactions:
Prev: 11/22/2023: Birdseye venture capital transaction
Next: 11/23/2023: Climate Alpha venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs